Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X5AN
|
|||
| Former ID |
DIB008151
|
|||
| Drug Name |
U300
|
|||
| Synonyms |
Methyl 3,5-dinitrobenzoate; 2702-58-1; Benzoic acid, 3,5-dinitro-, methyl ester; POGCCFLNFPIIGW-UHFFFAOYSA-N; 3,5-dinitro-benzoic acid methyl ester; Methyl 3,5-Dinitrobenzoate,99%; Methyl-3,5-dinitrobenzoate; U300; ACMC-1CR6Q; AC1L5B8W; AC1Q5AI0; KSC494Q3H; SCHEMBL418416; Jsp005266; CHEMBL2252127; CTK3J4833; KS-00000ZZJ; NSC7317; MolPort-001-012-121; Methyl 3,5-dinitrobenzoate, 99%; ALBB-024845; NSC-7317; ZINC1683476; METHYL-3,5-DINITRO BENZOATE; BBL000013; ANW-44565; SBB068882; MFCD00017016; STK386186; 3,5-Dinitrobenzoic acid methyl e
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 3 | [1] | |
| Company |
Sanofi us
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H6N2O6
|
|||
| Canonical SMILES |
COC(=O)C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-]
|
|||
| InChI |
1S/C8H6N2O6/c1-16-8(11)5-2-6(9(12)13)4-7(3-5)10(14)15/h2-4H,1H3
|
|||
| InChIKey |
POGCCFLNFPIIGW-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 2702-58-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
73217, 1919726, 3152492, 6646727, 9376684, 10516433, 16192414, 16957468, 24864085, 29198754, 30425287, 49761559, 56369666, 57399967, 58022987, 77299680, 85202811, 85246955, 88307520, 92710864, 93646310, 97857740, 103829232, 105574517, 113475329, 117558225, 117930475, 118498165, 125346650, 126545651, 126631441, 128777243, 128944548, 129873830, 130896636, 135544355, 136991348, 137169760, 143299004, 143439500, 144022224, 152225311, 160812063, 162098740, 162186771, 162281644, 162763151, 163376044, 163782142, 163810542
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Sanofi. | |||
| REF 2 | U300, a novel long-acting insulin formulation. Expert Opin Biol Ther. 2014 Dec;14(12):1849-60. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.